Monica Neagu

Selective immunosuppression by administration of major histocompatibility complex class II-binding peptides. II. Preventive inhibition of primary and secondary in vivo antibody responses

G. Rodríguez-Tarduchy, L. Adorini, J. Guéry, 1993, The Journal of experimental medicine.